Our Team

As experts and pioneers in the MPS-1
diagnostic field, with a personal stake
and experienced understating of the
real-life impact of Cancer on families
and friends, we are committed and
passionate about making precise
universal early detection screening
and monitoring options viable,
extending longevities and saving lives.

Our Team

As experts and pioneers in the MPS-1
diagnostic field, with a personal stake
and experienced understating of the
real-life impact of Cancer on families
and friends, we are committed and
passionate about making precise
universal early detection screening
and monitoring options viable,
extending longevities and saving lives.

Who We Are

Founders

24

Ronald R. Kuczer

CEO Marketing and Bus. Development

image2 4

Paul D. Hamilton

Chief Scientific Operating Officer

Group 32

Jose Alberto Fernandez-Pol

Original Scientific Basis Contributor

Founders

Vision

Ronald R. Kuczer

CEO Marketing and Bus. Development

Ronald is the Chief Executive Officer of the National Cancer screen. Driven by the loss of the entirety of generation of his family to cancer, he responsible for the rallying vision and establishment of a viable central MPS-1 diagnostic lab for Screening. Ronald has more than 29 years of experience in the MPS-1 project development, and 3 Years Fluid dynamics technology development and equipment engineering in medical electrophoresis operations in space at McDonnell Douglas. As entrepreneur, engineer, and national award-winning consumer product designer he brings 34 Years of business management, marketing and forward looking outside the box consumer product development to the company. In line with his compassionate missions, Ronald also has worked to incorporate elements of his businesses to focus on championing opportunities to workers with disabilities. Ronald holds a BSAE and. BSME from the University of Michigan.

Expert Technologist

Paul D. Hamilton

Chief Scientific Operating Officer

Paul is the chief scientific officer of the National Cancer Screen and an original investigational lab associate with over 29 years in MPS-1 development, responsible for having run the majority of MPS-1 tests in both research and clinical application. A proven research scientist with 40+ years of expertise in polymer chemistry, nanotechnology materials chemistry and hydrogels, Paul has published and co-authored over 60 peer review journal articles, along with multiple contributions to writing of successful grants in various technology fields. Paul holds a BA in biology and chemistry from Greenville University of Illinois.

Expert Technologist

Paul D. Hamilton

Chief Scientific Operating Officer

Paul is the chief scientific officer of the National Cancer Screen and an original investigational lab associate with over 21 years in mps-1 development, responsible for having run the majority of mps-1 tests in both research and clinical application. A proven research scientist with 40+ years of expertise in polymer chemistry, nanotechnology materials chemistry and hydrogels, Paul has published and co-authored over 60 peer review journal articles, along with multiple contributions to writing of successful grants in various technology fields. Paul holds a BA in biology and chemistry from Greenville University of Illinois.

scientific Basis

scientific Basis

Principal Investigator

Jose Alberto Fernandez-Pol

Original Scientific Contributor

Alberto is Paul’s original principal investigating associate & scientific contributor with whom Paul worked to develop MPS-1 Technologies and who’s work we continue to implement. A recognized expert in molecular biology with 35+ years of cancer research, drug discovery and laboratory management experience, Alberto is a physician with specialization in nuclear medicine, with post doctorate at the National Institute of Health, and previous full professor of radiology and nuclear medicine at St. Louis University.
Highly published, with 9 International patents, and his achievements include original findings in area of growth regulation and cancer, and discovery of a new human gene–the MPS-1 gene–denoted, metallopanstimulin. He is a member of the American Association Cancer Research, Society Biological Chemistry and Molecular Biology. Alberto holds an MD from the University of Buenos Aires, Argentina.
Scientific Basis

Based on the Science of Jose Alberto Fernandez-Pol

Original Scientific Basis Contributor

Alberto is Paul’s original principal investigating associate & scientific contributor with whom Paul worked to develop MPS-1 Technologies and who’s work we continue to implement.
Visionary

Ronald R. Kuczer,

CEO Marketing and Bus. Development

Ronald is the Chief Executive Officer of the National Cancer screen. Driven by the loss of the entirety of generation of his family to cancer, he responsible for the rallying vision and establishment of a viable central MPS-1 diagnostic lab for Screening.

Expert Technologist

Paul D. Hamilton

Chief Scientific Operating Officer

Paul is the chief scientific officer of the National Cancer Screen and an original investigational lab associate with over 21 years in mps-1 development, responsible for having run the majority of mps-1 tests in both research and clinical application.
HELP

SUPPORT OUR MISSION

*National Cancer Screen, llc is not a nonprofit. Donation is not tax deductible.